Showing results (741-750 of 896) with videos related to
Sort By:
Pageof 90
Journal of Molecular Recognition : JMR|April 9, 2009
Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changesVsevolod Katritch, Kimberly A Reynolds, Vadim Cherezov, et al.Retina (Philadelphia, Pa.)|November 30, 2007
Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferationDaniel B Roth, Ingrid U Scott, Jonathan M Gloth, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 10, 2003
Noninfectious endophthalmitis associated with intravitreal triamcinolone injectionDaniel B Roth, Janet Chieh, Marc J Spirn, et al.Zeitschrift Fur Geburtshilfe Und Neonatologie|June 24, 2006
[Pain management and coping behaviour in premature babies (< 1500 g) at corrected age of 36 months influence of neonatal experience and maternal anxiety]C Ganseforth, D Rödder, R Klein, et al.The Journal of Trauma|June 27, 2008
Surviving blood loss using hydrogen sulfideMichael L Morrison, Jennifer E Blackwood, Summer L Lockett, et al.Ophthalmology. Retina|May 4, 2019
Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular DegenerationAllen C Ho, Namrata Saroj, Keith Baker, et al.Journal of Clinical Microbiology|July 4, 2014
Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and BShuping Nie, Richard B Roth, Jeffrey Stiles, et al.British Journal of Anaesthesia|July 4, 2014
Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signallingB Müller-Edenborn, R Frick, T Piegeler, et al.Clinical and Experimental Pharmacology & Physiology|May 4, 1999
Urokinase plasminogen activator system in humans with stable coronary artery diseaseT L Krasnikova, Y Parfyonova, I A Alekseeva, et al.The British Journal of Ophthalmology|May 29, 2020
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN studySam E Mansour, Daniel F Kiernan, Daniel B Roth, et al.Pageof 90